elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30400249-1BA3D811-D38E-4D5D-B1B2-7824A15DB8FB
Q30400249-1BA3D811-D38E-4D5D-B1B2-7824A15DB8FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30400249-1BA3D811-D38E-4D5D-B1B2-7824A15DB8FB
Reversing the anticoagulation effects of dabigatran.
P2860
Q30400249-1BA3D811-D38E-4D5D-B1B2-7824A15DB8FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30400249-1BA3D811-D38E-4D5D-B1B2-7824A15DB8FB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f88760d25a2552e3b34cdfb9a0e6026903677c8c
P2860
Management of Dabigatran-Associated Bleeding with Two Doses of Idarucizumab Plus Hemodialysis.